aurintricarboxylic acid has been researched along with mesalamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, XX; Han, X; Hong, T; Hu, Y; Liu, H; Qi, Y; Sun, J; Wang, L; Wu, F; Yu, J; Zhang, T; Zhang, W; Zhou, Y | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
2 other study(ies) available for aurintricarboxylic acid and mesalamine
| Article | Year |
|---|---|
Discovery of a Bioactive Inhibitor with a New Scaffold for Cystathionine γ-Lyase.
Topics: Animals; Aurintricarboxylic Acid; Catalytic Domain; Cystathionine gamma-Lyase; Drug Discovery; Enzyme Inhibitors; HEK293 Cells; Humans; Male; Mice; Molecular Docking Simulation; Molecular Structure; Nitroquinolines; Protein Binding; Rats, Sprague-Dawley; RAW 264.7 Cells; Structure-Activity Relationship | 2019 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |